No evidence of asymptomatic variant CJD infection in immunodeficiency patients treated with UK‐sourced immunoglobulin

M. R. Helbert, C. Bangs, M. Bishop, A. Molesworth, J. Ironside

Research output: Contribution to journalArticlepeer-review

Abstract

Surveillance of 75 immunodeficiency patients exposed to UK‐sourced immunoglobulin, including batches derived from donors who went on to develop vCJD, has not detected any clinical cases of vCJD, or of asymptomatic infection in 15 patients with available tissue samples of sufficient quality for testing.

Original languageEnglish
Pages (from-to)282-284
Number of pages3
JournalVox Sanguinis
Volume110
Issue number3
Early online date3 Nov 2015
DOIs
Publication statusPublished - 6 Apr 2016

Fingerprint

Dive into the research topics of 'No evidence of asymptomatic variant CJD infection in immunodeficiency patients treated with UK‐sourced immunoglobulin'. Together they form a unique fingerprint.

Cite this